Lung Cancer News and Research

Latest Lung Cancer News and Research

Extended pleurectomy decortication plus chemotherapy associated with worse outcomes for mesothelioma patients

Extended pleurectomy decortication combined with chemotherapy is associated with worse survival outcomes, a higher incidence of serious adverse events, and a diminished quality of life compared to platinum and pemetrexed chemotherapy alone, according to research presented today the International Association for the Study of Lung Cancer (IASLC) 2023 World Conference on Lung Cancer in Singapore.

11 Sep 2023

Durvalumab shows tolerable surgical safety profile in patients with resectable NSCLC

Adding perioperative durvalumab to neoadjuvant chemotherapy did not adversely impact surgery in patients with resectable NSCLC and was associated with a tolerable surgical safety profile, according to research presented today from the phase 3 AEGEAN trial at the International Association for the Study of Lung Cancer 2023 World Conference on Lung Cancer in Singapore.

11 Sep 2023

Taiwan National Lung Cancer Early Detection Program offers hope for saving lives through early diagnosis

The Taiwan National Lung Cancer Early Detection Program detected 85 percent of lung cancer cases at either a phase 0 or phase 1 level, demonstrating that lung cancer screening can detect lung cancer at an early enough phase to allow doctors to intervene more effectively.

11 Sep 2023

Study aims to identify interventions to combat stigma associated with lung cancer and smoking-related respiratory diseases

The stigma that patients face when diagnosed with lung cancer is associated with poorer psychosocial outcomes, including distress and isolation, delayed help-seeking, and concerns about the quality of care, according to research presented today at the International Association for the Study of Lung Cancer (IASLC) 2023 World Conference on Lung Cancer in Singapore.

11 Sep 2023

Adagrasib shows durable clinical activity in KRAS-G12C-mutated NSCLC

The oral, selective KRAS G12C inhibitor The oral, selective KRAS G12C inhibitor KRAS-G12C inhibitor adagrasib demonstrated durable clinical activity, with a median overall survival of 14.1 months and approximately one in three patients alive at two years, according to research presented today at the International Association for the Study of Lung Cancer (IASLC) 2023 World Conference on Lung Cancer in Singapore.

11 Sep 2023

Study provides new hope for patients with stage III EGFR-mutant non-small cell lung cancer

The immunotherapy drug, durvalumab, has been the standard of care for patients with stage III non-small cell lung cancer(NSCLC) to improve survival, when prescribed after chemotherapy and radiation therapy.

11 Sep 2023

Non-invasive breath analysis could improve treatment of malignant pleural mesothelioma

Identifying and analyzing volatile organic compounds in exhaled breath of patients with malignant pleural mesothelioma showed promise as a screening method for MPM, according to research presented today at the International Association for the Study of Lung Cancer (IASLC) 2023 World Conference on Lung Cancer in Singapore.

11 Sep 2023

Exploring the anti-cancer potential of dark tea

The potential of dark tea in cancer prevention and management.

11 Sep 2023

Unlocking the genetic code of blood sugar reveals new diabetes risks and lung complications

The study used a genome-wide association study (GWAS) to analyze random glucose levels in nearly half a million non-diabetic subjects, uncovering 150 distinct genetic signals, including 53 new ones, linked to glycemic traits and type 2 diabetes. The research also discovered a causal effect of random glucose and type 2 diabetes on lung function, identifying lung dysfunction as a new diabetes complication.

10 Sep 2023

Is there an association between the COVID-19 pandemic and cancer incidence?

The COVID-19 pandemic influenced cancer incidence.

8 Sep 2023

Rising tide of early-onset cancers: Study predicts alarming increase by 2030

An international study published in BMJ Oncology analyzes the Global Burden of Disease 2019 dataset to explore the rising incidence and mortality rates of early-onset cancers (ages 14-49) worldwide. The study highlights varying cancer burdens by gender and region, identifies lifestyle and environmental risk factors, and predicts a significant increase in early-onset cancer rates by 2030.

7 Sep 2023

COVID-19 pandemic disrupted cancer diagnoses, raising alarms for future healthcare resilience

The COVID-19 pandemic led to a notable decline in new cancer diagnoses in Manitoba, Canada, particularly affecting breast, colon, and rectal cancers. The study highlights the urgent need for healthcare strategies to mitigate the impact of future disruptions on cancer detection and treatment.

6 Sep 2023

Amgen to discuss application for LUMAKRAS® (sotorasib) for the treatment of KRAS G12C-positive NSCLC at FDA advisory committee meeting

Amgen today announced the U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) will review data supporting the supplemental New Drug Application (sNDA) for the full approval of LUMAKRAS® (sotorasib) for adults with previously treated locally advanced or metastatic KRAS G12C-mutated non-small cell lung cancer (NSCLC) at a meeting on Oct. 5, 2023.

From AMGEN 1 Sep 2023

Antioxidants stimulate the formation of new blood vessels in lung cancer tumors

Vitamin C and other antioxidants stimulate the formation of new blood vessels in lung cancer tumors, a new study from Karolinska Institutet published in The Journal of Clinical Investigation shows.

31 Aug 2023

The Clinical Importance of Circulating Tumor DNA

Cancer remains a leading killer among medical causes of death worldwide.

31 Aug 2023

New discoveries about a type of immune cells could pave the way for improved immunotherapies

Fresh discoveries about a type of immune cells could give lung cancer patients a more accurate prognosis and better identify who will benefit from immunotherapies.

30 Aug 2023

Study highlights challenges of shared decision-making in advanced lung cancer care

A new study shows that patients can experience reduced co-determination and insufficient information about their cancer treatment, while doctors face pressure to give treatment they do not consider useful.

28 Aug 2023

Integrating tobacco cessation care into lung cancer screening improves quit rates

Lung cancer is the deadliest cancer in the United States, and 80% of lung cancer deaths are linked to one risk factor: smoking.

25 Aug 2023

ChatGPT 3.5 provides inappropriate cancer treatment recommendations in one-third of cases, study shows

For many patients, the internet serves as a powerful tool for self-education on medical topics. With ChatGPT now at patients' fingertips, researchers from Brigham and Women's Hospital, a founding member of the Mass General Brigham healthcare system, assessed how consistently the artificial intelligence chatbot provides recommendations for cancer treatment that align with National Comprehensive Cancer Network (NCCN) guidelines.

25 Aug 2023

Study shows how cancer can selfishly hijack a helpful immune pathway to spread

A study led by researchers at Memorial Sloan Kettering Cancer Center (MSK) and Weill Cornell Medicine discovered a new relationship between cancer cells and the immune system, and shows how cancer can selfishly hijack a normally helpful immune pathway.

23 Aug 2023

Lung Cancer News and Research

Latest Lung Cancer News and Research

Extended pleurectomy decortication plus chemotherapy associated with worse outcomes for mesothelioma patients

Durvalumab shows tolerable surgical safety profile in patients with resectable NSCLC

Taiwan National Lung Cancer Early Detection Program offers hope for saving lives through early diagnosis

Study aims to identify interventions to combat stigma associated with lung cancer and smoking-related respiratory diseases

Adagrasib shows durable clinical activity in KRAS-G12C-mutated NSCLC

Study provides new hope for patients with stage III EGFR-mutant non-small cell lung cancer

Non-invasive breath analysis could improve treatment of malignant pleural mesothelioma

Exploring the anti-cancer potential of dark tea

Unlocking the genetic code of blood sugar reveals new diabetes risks and lung complications

Is there an association between the COVID-19 pandemic and cancer incidence?

Rising tide of early-onset cancers: Study predicts alarming increase by 2030

COVID-19 pandemic disrupted cancer diagnoses, raising alarms for future healthcare resilience

Amgen to discuss application for LUMAKRAS® (sotorasib) for the treatment of KRAS G12C-positive NSCLC at FDA advisory committee meeting

Antioxidants stimulate the formation of new blood vessels in lung cancer tumors

The Clinical Importance of Circulating Tumor DNA

New discoveries about a type of immune cells could pave the way for improved immunotherapies

Study highlights challenges of shared decision-making in advanced lung cancer care

Integrating tobacco cessation care into lung cancer screening improves quit rates

ChatGPT 3.5 provides inappropriate cancer treatment recommendations in one-third of cases, study shows

Study shows how cancer can selfishly hijack a helpful immune pathway to spread

The ultimate guide to lung research tools and protocols eBook

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Lung Cancer News and Research

Latest Lung Cancer News and Research

The ultimate guide to lung research tools and protocols eBook

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Newsletters you may be interested in